133 related articles for article (PubMed ID: 10380908)
21. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.
Lepin EJ; Bastin JM; Allan DS; Roncador G; Braud VM; Mason DY; van der Merwe PA; McMichael AJ; Bell JI; Powis SH; O'Callaghan CA
Eur J Immunol; 2000 Dec; 30(12):3552-61. PubMed ID: 11169396
[TBL] [Abstract][Full Text] [Related]
22. Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages.
Lamar DL; Weyand CM; Goronzy JJ
Blood; 2010 Apr; 115(16):3278-86. PubMed ID: 20194892
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
Willcox BE; Thomas LM; Chapman TL; Heikema AP; West AP; Bjorkman PJ
BMC Struct Biol; 2002 Oct; 2():6. PubMed ID: 12390682
[TBL] [Abstract][Full Text] [Related]
24. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
[TBL] [Abstract][Full Text] [Related]
25. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor.
Morel E; Bellón T
Allergy; 2007 Feb; 62(2):190-6. PubMed ID: 17298429
[TBL] [Abstract][Full Text] [Related]
26. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia.
Villa-Álvarez M; Sordo-Bahamonde C; Lorenzo-Herrero S; Gonzalez-Rodriguez AP; Payer AR; Gonzalez-Garcia E; Villa-Álvarez MC; López-Soto A; Gonzalez S
Front Immunol; 2018; 9():2917. PubMed ID: 30619281
[TBL] [Abstract][Full Text] [Related]
27. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.
Cosman D; Fanger N; Borges L
Immunol Rev; 1999 Apr; 168():177-85. PubMed ID: 10399074
[TBL] [Abstract][Full Text] [Related]
28. Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies.
Garner LI; Salim M; Mohammed F; Willcox BE
Protein Expr Purif; 2006 Jun; 47(2):490-7. PubMed ID: 16406677
[TBL] [Abstract][Full Text] [Related]
29. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
Pende D; Biassoni R; Cantoni C; Verdiani S; Falco M; di Donato C; Accame L; Bottino C; Moretta A; Moretta L
J Exp Med; 1996 Aug; 184(2):505-18. PubMed ID: 8760804
[TBL] [Abstract][Full Text] [Related]
30. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses.
Naji A; Menier C; Morandi F; Agaugué S; Maki G; Ferretti E; Bruel S; Pistoia V; Carosella ED; Rouas-Freiss N
J Immunol; 2014 Feb; 192(4):1536-46. PubMed ID: 24453251
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
32. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j).
Shiroishi M; Kuroki K; Tsumoto K; Yokota A; Sasaki T; Amano K; Shimojima T; Shirakihara Y; Rasubala L; van der Merwe PA; Kumagai I; Kohda D; Maenaka K
J Mol Biol; 2006 Jan; 355(2):237-48. PubMed ID: 16305801
[TBL] [Abstract][Full Text] [Related]
33. Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1).
Kirwan SE; Burshtyn DN
J Immunol; 2005 Oct; 175(8):5006-15. PubMed ID: 16210603
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
Chapman TL; Heikema AP; West AP; Bjorkman PJ
Immunity; 2000 Nov; 13(5):727-36. PubMed ID: 11114384
[TBL] [Abstract][Full Text] [Related]
35. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.
Colonna M; Nakajima H; Navarro F; López-Botet M
J Leukoc Biol; 1999 Sep; 66(3):375-81. PubMed ID: 10496306
[TBL] [Abstract][Full Text] [Related]
36. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones.
Vitale M; Castriconi R; Parolini S; Pende D; Hsu ML; Moretta L; Cosman D; Moretta A
Int Immunol; 1999 Jan; 11(1):29-35. PubMed ID: 10050671
[TBL] [Abstract][Full Text] [Related]
37. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
Ryu M; Chen Y; Qi J; Liu J; Fan Z; Nam G; Shi Y; Cheng H; Gao GF
PLoS One; 2011 Apr; 6(4):e19245. PubMed ID: 21559424
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor.
Willcox BE; Thomas LM; Bjorkman PJ
Nat Immunol; 2003 Sep; 4(9):913-9. PubMed ID: 12897781
[TBL] [Abstract][Full Text] [Related]
39. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.
López-Botet M; Angulo A; Gumá M
Tissue Antigens; 2004 Mar; 63(3):195-203. PubMed ID: 14989708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]